Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems

被引:3
|
作者
Ben Slama, Sana [1 ]
Ben Ghachem, Dorra [2 ]
Dhaoui, Amen [2 ]
Jomni, Mohamed Taieb [3 ]
Dougui, Mohamed Hedi [3 ]
Bellil, Khadija [2 ]
机构
[1] Hop M Slim La Marsa, Serv Anat Pathol, 2046 Sidi Daoud, Tunis, Tunisia
[2] Hop FSI La Marsa, Serv Anat Pathol, La Marsa, Tunisia
[3] Hop FSI La Marsa, Serv Gastroenterol, La Marsa, Tunisia
来源
关键词
Chronic gastritis; helicobacter pylori; atrophic gastritis; intestinal metaplasia; staging;
D O I
10.11604/pamj.2016.23.28.8839
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Helicobacter pylori (H pylori) gastritis presents a risk of cancer related to atrophy and intestinal metaplasia. Two recent classifications OLGA (Operative Link on Gastritis Assessment) and OLGIM (Operative Link on Gastritic Intestinal Metaplasia assessment) have been proposed to identify high-risk forms (stages III and IV). The aim of this study is to evaluate the OLGA and OLGIM staging systems in H pylori gastritis. A descriptive study of 100 cases of chronic H pylori gastritis was performed. The revaluation of Sydney System parameters of atrophy and intestinal metaplasia, of gastric antrum and corpus, allowed identifying respectively the stages of OLGA and OLGIM systems. The progressive risk of our H pylori gastritis was 6% according to OLGA staging and 7% according to OLGIM staging. Significant correlation was revealed between age and OLGA staging. High-risk gastritis according to OLGIM staging was significantly associated with moderate to severe atrophy. High-risk forms according to OLGA staging were associated in 80% of the cases to intestinal metaplasia. OLGA and OLGIM systems showed a highly significant positive correlation between them with a mismatch at 5% for H pylori gastritis. The OLGA and OLGIM staging systems in addition to Sydney System, allow selection of high risk forms of chronic gastritis requiring accurate observation.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] GASTRITIS AND HELICOBACTER-PYLORI
    SHEE, V
    NEVES, B
    BAPTISTA, C
    QUINA, M
    GASTROENTEROLOGY, 1995, 108 (04) : A248 - A248
  • [42] Helicobacter pylori and granulomatous gastritis
    Roblin, X
    Boudemaghe, T
    Paris, F
    Pellissier, L
    Le Gall, S
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 (04): : 416 - 417
  • [43] Helicobacter pylori gastritis in Africa
    Kuipers, EJ
    Meijer, GA
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (06) : 601 - 603
  • [44] Immunopathology of Helicobacter pylori gastritis
    Kirchner, T
    Steininger, H
    Faller, G
    DIGESTION, 1997, 58 : 14 - 16
  • [45] HELICOBACTER-PYLORI AND GASTRITIS
    DRUMM, B
    SHERMAN, P
    DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (06) : 962 - 962
  • [46] Helicobacter pylori and the evolution of gastritis
    Stolte, M
    Eidt, S
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 : 13 - 16
  • [47] HELICOBACTER-PYLORI AND GASTRITIS
    GUERRE, J
    GAZETTE MEDICALE, 1990, 97 (36): : 31 - 33
  • [48] The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis
    Capelle, Lisette G.
    de Vries, Annemarie C.
    Haringsma, Jelle
    Ter Borg, Frank
    de Vries, Richard A.
    Bruno, Marco J.
    van Dekken, Herman
    Meijer, Jos
    van Grieken, Nicole C. T.
    Kuipers, Ernst J.
    GASTROINTESTINAL ENDOSCOPY, 2010, 71 (07) : 1150 - 1158
  • [49] Interobserver agreement in the assessment of gastritis reversibility after Helicobacter pylori eradication
    Tepes, B
    Ferlan-Marolt, V
    Jutersek, A
    Kavcic, B
    Zaletel-Kragelj, L
    HISTOPATHOLOGY, 1999, 34 (02) : 124 - 133
  • [50] Helicobacter pylori gastritis and duodenogastric reflux
    Manifold, DK
    Pasztorova, I
    Sanderson, JD
    Anggiansah, A
    Chinyama, C
    Owen, WJ
    GUT, 1999, 44 : A119 - A119